基于生物发光的快速杀灭速率测定法用于抗疟药物发现
该研究验证了一种基于生物发光的相对杀灭速率(BRRoK)测定法,通过暴露于0.33×至9× IC50浓度监测恶性疟原虫的无性体阶段。
要点
- BRRoK测定法可快速评估抗疟药物的初始杀灭速率。
- 17个化合物的初始相对杀灭速率高于双氢青蒿素。
核心结论
- BRRoK测定法为抗疟药物关键药效学特性提供了快速测定格式,可扩展用于高通量筛选和药物开发决策。
研究设计与样本
- 采用改良的浓度-反应生物发光测定法,使用0.33×至9× IC50浓度,监测372个Malaria Box化合物对恶性疟原虫红内期无性体的即时杀灭效果。
主要发现
- 产生快速杀灭效果的抗疟药物引起浓度依赖的生物发光信号丢失,与体外和体内寄生虫清除时间和寄生虫减少比率的估计相关。
临床怎么用
- 该测定法简单稳健,可快速评估抗疟药物的初始杀灭速率,适用于高通量筛选和药物开发决策。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: A future treatment for uncomplicated malaria will contain at least one component that exerts a rapid rate of kill. We describe here the validation and application of a simple, robust and rapid bioluminescence-based assay for the determination of the initial rate of kill in intra-erythrocytic asexual stages of Plasmodium falciparum . METHODS: A modification to the concentration-response bioluminescence [here termed bioluminescence relative rate of kill (BRRoK)] assay, utilizing exposure to fold-IC 50 concentrations (0.33× to 9×), was used to monitor the immediate cytocidal effect of 372 open-source compounds for antimalarial drug discovery available through the Medicines for Malaria Venture Malaria Box. RESULTS: Antimalarial drugs that exert a rapid cytocidal effect produce a concentration-dependent loss of bioluminescence signal that correlates with available in vitro and in vivo estimates of parasite clearance time and parasite reduction ratio. Following the measurement of IC 50 for the Malaria Box compounds in Dd2 luc , the BRRoK assay was used to identify and rank 372 compounds for their initial cytocidal activity. Fifty-three compounds in the Malaria Box show an initial relative rate of kill greater than that of chloroquine, with 17 of these having an initial relative rate of kill greater than that of dihydroartemisinin. CONCLUSIONS: The BRRoK assay provides a rapid assay format for the estimation of a key pharmacodynamic property of antimalarial drug action. The simplicity and robustness of the assay suggests it would be readily scalable for high-throughput screening and a critical decision-making tool for antimalarial drug development.
引用
- Ullah I, Sharma R, Biagini GA, et al. A validated bioluminescence-based assay for the rapid determination of the initial rate of kill for discovery antimalarials. J Antimicrob Chemother. 2017. PMID: 27999014. doi:10.1093/jac/dkw449
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。